Hsbc Holdings PLC Atara Biotherapeutics, Inc. Transaction History

Hsbc Holdings PLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$0.44 - $1.22 $4,956 - $13,742	11,264 New	11,264 $7,000
Q4 2019 Feb 14, 2020	SELL	$10.89 - $16.79 $132,063 - $203,612	-12,127 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$12.03 - $19.94 $145,887 - $241,812	12,127 New	12,127 $171,000
Q3 2018 Nov 13, 2018	SELL	$35.05 - $43.5 $2.61 Million - $3.24 Million	-74,433 Closed	0 $0
Q2 2018 Aug 10, 2018	SELL	$35.15 - $51.45 $218,808 - $320,276	-6,225 Reduced 7.72%	74,433 $2.74 Million
Q1 2018 May 11, 2018	BUY	$18.0 - $48.35 $1.45 Million - $3.9 Million	80,658 New	80,658 $3.15 Million

2.89M

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $1.26B
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

Stay updated on Hsbc Holdings PLC with notifications on news.